07-06-2021 / Learn about CRISPR/Cas9-based non-viral knockin for T cell engineering and how the Marson lab at UCSF is optimizing these methods to support T cell therapies.

06-21-2021 / Learn about advances using CRISPR/Cas13 nucleases in viral detection and treatment, including influenza A and SARS-CoV-2.

03-17-2021 / Learn how long stranded DNA (lssDNA) donor templates facilitates knockin CRISPR/Cas9 editing efficiency for animal model generation.

03-11-2021 / Learn how CRISPR/Cas9 gene-editing ex vivo and in vivo approaches are progressing to treat beta-thalassemia, sickle cell disease, Leber congenital amaurosis, and hereditary transthyretin amyloidosis.

11-29-2020 / Novel CRISPR-based Non-viral Approach for CAR T Cell Generation

11-22-2020 / Overcoming Antibiotic Resistance with CRISPR

11-12-2020 / Learn about strategies to improve the efficiency of CRISPR mediated knock-in of donor DNA templates.

11-01-2020 / CRISPR/Cas9 Used to Edit Gene Variance in Human Stem cell-derived β cells from a Patient with Monogenic Diabetes and Reverse Preexisting Diabetes in Mice

10-26-2020 / Learn about Jennifer Doudna and Emmanuelle Charpentier, the 2020 Nobel prize-Chemistry recipients, for elucidating CRISPR/Cas9’s mechanisms in bacterial immunity as well as its potential for genome editing applications.